Hemopharm's Unattributed VC Round

Hemopharm raised a round of funding on August 31, 2017. Investors include Primer Capital.

Hemoparhm is developing a drug candidate to help multiple myeloma patients.…

Articles about Hemopharm's Unattributed VC Round: